Cell culture and animal studies have also shown that treatments that included IFN-α inhibited the proliferation and metastasis of hepatocellular carcinoma [14], gastric cancer, and pancreatic cancer cells [15]. This evidence concerns the gene IFNA1 and gastric cancer.